Singapore approves Pfizer’s oral COVID-19 medicine Paxlovid
[ad_1] Paxlovid, a Pfizer’s coronavirus disease (COVID-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021. Pfizer/Handout via REUTERS /File Photo SINGAPORE, Feb 3 (Reuters) – Singapore has approved Pfizer’s (PFE.N) oral COVID-19 medicine Paxlovid, its Health Sciences Authority (HSA) said on Thursday. Paxlovid is […]
Continue Reading